|
|
|
|
Percentage Change
from Preceding Year
|
|
|
2002
|
2001
|
2000
|
|
2002
|
|
2001
|
|
Sales
|
$51,790.3
|
$47,715.7
|
$40,363.2
|
|
+9%
|
|
+18%
|
|
Research and development expenses
|
2,677.2
|
2,456.4
|
2,343.8
|
|
|
|
|
|
Net income
|
7,149.5
|
7,281.8
|
6,821.7
|
|
-2%
|
|
+7%
|
|
Earnings per common share assuming dilution
|
$3.14
|
$3.14
|
$2.90
|
|
—
|
|
+8%
|
|
Dividends paid per common share
|
$1.41
|
$1.37
|
$1.21
|
|
+3%
|
|
+13%
|
|
Average common shares outstanding assuming dilution (millions)
|
2,277.0
|
2,322.3
|
2,353.2
|
|
|
|
|
|
Total assets
|
47,561.2
|
44,021.2
|
40,154.9
|
|
|
|
|
|
Capital expenditures
|
2,369.7
|
2,724.7
|
2,727.8
|
|
|
|
|
|
Net income as a % of average total assets
|
15.6%
|
17.3%
|
17.9%
|
|
|
|
|
|
Number of stockholders of record
|
246,300
|
256,200
|
265,700
|
|
|
|
|
|
Number of employees
|
77,300
|
78,100
|
69,300
|
|
|
|
|
|
|
|
|
|
|
|
|
